Situation: A large pharmaceutical company had completed pivotal clinical trials for a breakthrough immuno-oncology drug demonstrating significant tumor shrinkage and improved patient survival rates.
Challenges:
Ensuring timely publication of positive clinical trial data in high-impact oncology journals to maximize pre-launch visibility and scientific credibility.
Identifying the most appropriate journals for each data set, considering readership, impact factor, and specific focus within the field of immuno-oncology.
Collaborating with internal medical writers to ensure accurate and compelling presentation of the clinical trial data, adhering to journal submission guidelines.
Impact:
Developed a strategic publication plan, prioritizing journals based on their audience reach and relevance to the specific type of cancer targeted by the drug.
Worked closely with internal medical writers to develop well-structured manuscripts that effectively showcased the drug's efficacy and safety profile.
Proactively addressed any reviewer inquiries or concerns to ensure smooth publication processes and minimize delays.
Secured publication of pivotal trial data in top-tier oncology journals, generating significant pre-launch buzz and excitement among oncologists.
Results: The well-defined publication strategy secured the publication of pivotal trial data in top oncology journals, maximizing visibility and scientific credibility. This generated significant pre-launch interest and excitement among oncologists for the new breakthrough drug.
Comentarios